Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

PANVAX® PANDEMIC INFLUENZA VACCINE (ADJUVANTED) 10ML SUSPENSION FOR INJECTION VIAL [SIN15801P]

Active ingredients: PANVAX® PANDEMIC INFLUENZA VACCINE (ADJUVANTED) 10ML SUSPENSION FOR INJECTION VIAL

View product's general information
Last updated 24 April 2026

Product Info

PANVAX® PANDEMIC INFLUENZA VACCINE (ADJUVANTED) 10ML SUSPENSION FOR INJECTION VIAL

[SIN15801P]

Product information

Active Ingredient and Strength

PANDEMIC INFLUENZA VIRUS TYPE A, INACTIVATED AND DISRUPTED - 30 MCG HA/0.5 ML

Dosage Form

INJECTION, SUSPENSION

Manufacturer and Country

SEQIRUS PTY LTD - AUSTRALIA

Registration Number

SIN15801P

Licence Holder

SEQIRUS PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

J07BB02

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

Therapeutic indications

Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with Singaporean Health Authorities’ recommendations, taking into account the recommendation of the World Health Organisation.

Dosing

Dosage and method of administration

Dose

Two 0.5 mL doses, 21 days apart.

Method of administration

The vaccine should be administered by intramuscular injection.

The vaccine should be allowed to reach room temperature before use. Shake before use. The vaccine should appear as a homogeneous creamy/white opaque liquid suspension with no large clumps visible.

Once opened, the vaccine is to be used immediately and within the one vaccination session, with any remaining contents discarded in accordance with local requirements. No additions should be made to the contents of the vial.

Instructions for use and handling

It is important that the contents of the container be shaken thoroughly immediately before use. The vaccine should appear as a homogenous creamy/white opaque liquid suspension with no large clumps visible.

Contraindications

Contraindications

History of an anaphylactic (i.e. life-threatening) reaction to any of the constituents or trace residues (e.g. eggs, chicken protein refer to sections Qualitative and Quantitative Composition and List of excipients – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information) of this vaccine. However, in a pandemic situation, it may be appropriate to give the vaccine, provided that facilities for resuscitation are immediately available in case of need.